← Back to Search

Procedure

Baylis Versacross RF wire for Atrial Fibrillation (WIRE-IT Trial)

N/A
Waitlist Available
Led By Greg Marcus, MD, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-60 minutes (summation of first transseptal and second transseptal times)
Awards & highlights

WIRE-IT Trial Summary

This trial is comparing two ways of puncturing through a thin wall in the heart, to see which is better.

Eligible Conditions
  • Atrial Fibrillation
  • Atrial Flutter

WIRE-IT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-60 minutes (summation of first transseptal and second transseptal times)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-60 minutes (summation of first transseptal and second transseptal times) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to Achieve First Transseptal Puncture
Secondary outcome measures
Combined Transseptal Time
Complication Rates
Fluoroscopy Time
+2 more

WIRE-IT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Baylis Versacross RF wireExperimental Treatment1 Intervention
Device: Baylis Versacross radiofrequency wire
Group II: Baylis RF NeedleActive Control1 Intervention
Device: conventional Baylis radiofrequency needle
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Baylis Versacross RF wire
2020
N/A
~80

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,480 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
19,049 Patients Enrolled for Atrial Fibrillation
Baylis Medical CompanyIndustry Sponsor
9 Previous Clinical Trials
705 Total Patients Enrolled
3 Trials studying Atrial Fibrillation
463 Patients Enrolled for Atrial Fibrillation
Greg Marcus, MD, MASPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
120 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still occurring?

"According to records available on clinicaltrials.gov, this particular trial is no longer actively seeking participants. It was first made public on November 30th 2020 before it's last update of March 21st 2022. Although recruitment has ended for this study, 482 other trials are currently enrolling volunteers at the present moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency
2020. "Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04645342.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top